From Transcripts to Research Platform
Sr. Customer Operations Leader at Tegus on the Costco model of investment research
The shift to an all in one platform was really a move to own the investor's full research workflow, not just one input into it. Tegus started with expert transcripts, but those transcripts were most useful when an analyst could immediately compare them to company filings in BAMsec and plug the takeaways into Canalyst models. That made the product stickier, raised seat value, and pushed more of the research day into one interface.
-
The core job was concrete. A hedge fund analyst might read an expert transcript to test a view on demand, open the company's SEC filings to check management's language, then update a revenue or margin assumption in a model. BAMsec and Canalyst filled those next two steps directly.
-
This also changed the business model from a cheaper call broker into a research subscription. Tegus charged expert calls roughly at cost, while the higher value product was the library and bundled access. Adding filings and models increased how much a seat could justify and how hard it was to rip out.
-
The broader market was moving the same way. Large funds increasingly expected one vendor to have everything, and Tegus explicitly saw breadth as necessary to compete with platforms like AlphaSense, Bloomberg, FactSet, and other investment workstations, not just expert networks like GLG or GuidePoint.
From here, the winning products are likely to look less like separate data tools and more like a single research surface that turns transcripts, filings, earnings calls, and models into instant answers. The more these datasets are linked and searchable together, the more platform breadth becomes the moat and the less room remains for narrow standalone tools.